Pharmaceuticals
Founded in 2003 in Sydney Australia. New Zealand subsidiary set up in 2005. Largest supplier of generic & private label products in Australasia. Acquired by Marksans Pharma in 2005.
Company Ownership
Nova Pharmaceuticals Australasia Pty Ltd
AUS
Marksans Pharma Ltd
owns 60% of Nova Pharmaceuticals Australasia Pty Ltd
IND
Pharmaceuticals
Acquired Nova Pharmaceuticals in 2005.
Company Assessment
(Last updated Apr 2025)
Praise
Criticism
Information
Nova Pharmaceuticals Australasia Pty Ltd
No assessment data currently available for Nova Pharmaceuticals Australasia Pty Ltd.
Marksans Pharma Ltd
Praise
Information
Criticism
High ESG Risk
Sustainalytics, a top ESG research firm, evaluates environmental, social, and governance risks for over 16,000 companies. Its ESG Risk Rating reflects how much risk a company faces in its industry and how well it manages those risks. The final score includes both unmanaged and unmanageable risks, and companies are rated on a scale from negligible (0-10) to severe (40+). This company received an ESG Risk Rating of 38.2, placing it in the "high risk" category (retrieved April 2025).
Source: Sustainalytics
(2025)
Company Details
Type:
Wholly-owned subsidiary
Founded:
2003
Contact Details
Address:
Suite 305, 10 Norbrik Drive, Bella Vista, NSW, 2153, Australia
Phone:
02 8090 7855
Website:
Products / Brands
Nova Pharmaceuticals
Medix
Medicinal Oils